E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas - PubMed (original) (raw)

. 1995 Nov 15;55(22):5195-9.

Affiliations

• PMID: 7585573

E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas

J R Graff et al. Cancer Res. 1995.

Abstract

Expression of the Ca(2+)-dependent, homotypic cell:cell adhesion molecule, E-cadherin (E-cad), suppresses tumor cell invasion and metastasis in experimental tumor models. Decreased E-cad expression is common in poorly differentiated, advanced-stage carcinomas. These data implicate E-cad as an "invasion suppressor" gene. The mechanism by which E-cad is silenced in advanced stage carcinomas is unclear. In this report, we show that: (a) the 5' CpG island of E-cad is densely methylated in E-cad-negative breast and prostate carcinoma cell lines and primary breast carcinoma tissue but is unmethylated in normal breast tissue; (b) treatment with the demethylating agent, 5-aza-2'-deoxycytidine, partially restores E-cad RNA and protein levels in E-cad-negative breast and prostate carcinoma cell lines; and (c) and E-cad promoter/CAT construct is expressed in both E-cad-positive and -negative breast and prostate carcinoma cell lines, indicating that these cells have the active transcriptional machinery necessary for E-cad expression. Our data demonstrate that frequent loss of E-cad expression in human breast and prostate carcinomas results from hypermethylation of the E-cad promoter region.

PubMed Disclaimer

Similar articles

• Promoter-hypermethylation associated defective expression of E-cadherin in primary non-small cell lung cancer.
  Wang G, Hu X, Lu C, Su C, Luo S, Luo ZW. Wang G, et al. Lung Cancer. 2008 Nov;62(2):162-72. doi: 10.1016/j.lungcan.2008.03.023. Epub 2008 May 12. Lung Cancer. 2008. PMID: 18468719
• Loss of expression and aberrant methylation of the CDH13 (H-cadherin) gene in breast and lung carcinomas.
  Toyooka KO, Toyooka S, Virmani AK, Sathyanarayana UG, Euhus DM, Gilcrease M, Minna JD, Gazdar AF. Toyooka KO, et al. Cancer Res. 2001 Jun 1;61(11):4556-60. Cancer Res. 2001. PMID: 11389090
• Extinction of E-cadherin expression in breast cancer via a dominant repression pathway acting on proximal promoter elements.
  Hajra KM, Ji X, Fearon ER. Hajra KM, et al. Oncogene. 1999 Dec 2;18(51):7274-9. doi: 10.1038/sj.onc.1203336. Oncogene. 1999. PMID: 10602481
• Downregulation in vivo of the invasion-suppressor molecule E-cadherin in experimental and clinical cancer.
  Mareel M, Vleminckx K, Vermeulen S, Yan G, Bracke M, van Roy F. Mareel M, et al. Princess Takamatsu Symp. 1994;24:63-80. Princess Takamatsu Symp. 1994. PMID: 8983064 Review.
• Molecular genetics of prostate cancer: clinical applications.
  Morton RA Jr, Isaacs WB. Morton RA Jr, et al. J Natl Med Assoc. 1998 Nov;90(11 Suppl):S728-31. J Natl Med Assoc. 1998. PMID: 9828591 Free PMC article. Review. No abstract available.

Cited by

• The Wilms' tumor gene (WT1) regulates E-cadherin expression and migration of prostate cancer cells.
  Brett A, Pandey S, Fraizer G. Brett A, et al. Mol Cancer. 2013 Jan 8;12:3. doi: 10.1186/1476-4598-12-3. Mol Cancer. 2013. PMID: 23298185 Free PMC article.
• Clinical evaluation of E-cadherin expression and its regulation mechanism in epithelial ovarian cancer.
  Yuecheng Y, Hongmei L, Xiaoyan X. Yuecheng Y, et al. Clin Exp Metastasis. 2006;23(1):65-74. doi: 10.1007/s10585-006-9020-3. Epub 2006 Jul 7. Clin Exp Metastasis. 2006. PMID: 16826427
• Co-culturing human prostate carcinoma cells with hepatocytes leads to increased expression of E-cadherin.
  Yates CC, Shepard CR, Stolz DB, Wells A. Yates CC, et al. Br J Cancer. 2007 Apr 23;96(8):1246-52. doi: 10.1038/sj.bjc.6603700. Epub 2007 Apr 3. Br J Cancer. 2007. PMID: 17406365 Free PMC article.
• Aberrant methylation of the vascular endothelial growth factor receptor-1 gene in prostate cancer.
  Yamada Y, Watanabe M, Yamanaka M, Hirokawa Y, Suzuki H, Takagi A, Matsuzaki T, Sugimura Y, Yatani R, Shiraishi T. Yamada Y, et al. Cancer Sci. 2003 Jun;94(6):536-9. doi: 10.1111/j.1349-7006.2003.tb01479.x. Cancer Sci. 2003. PMID: 12824880 Free PMC article.
• Prostate Cancer - Old Problems and New Approaches. (Part II. Diagnostic and Prognostic Markers, Pathology and Biological Aspects).
  Honn KV, Aref A, Chen YQ, Cher ML, Crissman JD, Forman JD, Gao X, Grignon D, Hussain M, Porter AT, Pontes EJ, Powell I I, Redman B, Sakr W, Severson R, Tang DG, Wood DP Jr. Honn KV, et al. Pathol Oncol Res. 1996;2(3):191-211. doi: 10.1007/BF02903527. Pathol Oncol Res. 1996. PMID: 11173606

Publication types

MeSH terms

Substances

LinkOut - more resources

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information

• Miscellaneous

  • NCI CPTAC Assay Portal